Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
Department of Health and Human Services
Description
The National Center for Advancing Translational Sciences (NCATS) will soon re-issue a funding opportunity for the Rare Diseases Clinical Research Consortia (RDCRC) as part of the Rare Diseases Clinical Research Network. This grant supports research to improve diagnosis, management, and treatment of rare diseases through collaborative, multi-site projects. The funding notice is expected to be published in May 2025, with application deadlines in June and fall 2025. Each consortium should focus…
The objective of this Notice of Funding Opportunity (NOFO) is to invite new and renewal applications for the Rare Diseases Clinical Research Consortia (RDCRC) that comprise the Rare Diseases Clinical Research Network (RDCRN). The RDCRCs are intended to advance and improve diagnosis, management, …
Source
Grant ID
PAR-25-438
Agency
Department of Health and Human Services
Subcategory/Subagency
National Institutes of Health
Eligibility
The following categories of applicants are invited to apply:
- Small businesses
- Native American tribal governments (Federally recognized)
- Private institutions of higher education
- Independent school districts
- Public housing authorities/Indian housing authorities
- County governments
- Public and State controlled institutions of higher education
- For profit organizations other than small businesses
- State governments
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Native American tribal organizations (other than Federally recognized tribal governments)
- City or township governments
Awards & Funding
Award Ceiling
$1M
Funding Amount
Discretionary
Links
Similar opportunities
- Early Stage Clinical Trials for Novel Mechanism of Action Drugs or Devices for Psychiatric Disorders
National Institutes of Health
- Forecast to Publish a Funding Opportunity Announcement for Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional)
Department of Health and Human Services
- NIMH Clinical Trial Pilot Studies for Novel Psychosocial Interventions
National Institutes of Health
- Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
Department of Health and Human Services
- Notice of Funding Opportunity (NOFO) for Clinical Observational Studies
National Institutes of Health